MNX Global Logistics has opened a dedicated supply chain and logistics hub just outside Schiphol Airport in Amsterdam to meet increased demand for its services.
The facility with validated temperature-controlled supply chain capabilities will serve as the operations and warehousing hub for the US firm's life sciences and medical device customers across Europe.
'The demand for our services particularly in biologics, cold chain and medical devices logistics in the EMEA region has been tremendous and we have seen double digit growth in the past 12 months,' said Paul Martins, MNX CEO and President.
The capacity of the new HACCP and GDP compliant facility exceeds 1,300m2 with the option to expand by an additional 1,700m2. It has been designed to exceed the highest standards in the handling and movement of critical biopharmaceutical, radiopharmaceutical and medical device shipments.
The demand for our services particularly in biologics, cold chain and medical devices logistics in the EMEA region has been tremendous
The facility features –20ºC, 2–8ºC and 18ºC temperature-controlled storage with 24/7 monitoring, back-up systems and state-of-the-art security to ensure the constant integrity and security of temperature controlled and high value shipments.
'The new Life Sciences Logistics Centre in Amsterdam allows us to provide cross docking, inventory storage and transportation for our clients needing temperature sensitive control,' said Jan Willem Van ‘t Riet, MNX Senior Vice President for EMEA.
'In addition, our customers will benefit from our strict adherence to industry wide compliance procedures and protocols and our direct ramp access to personally deliver and retrieve critical shipments from the airlines that serve Amsterdam Airport Schiphol.'
Headquartered in Irvine, CA, MNX maintains regional headquarters in Singapore, Amsterdam and Miami. The company serves more than 190 countries, including key Asia Pacific, South American and EMEA markets.
